Douglas C. Lane & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$8.85M Sell
86,162
-1,154
-1% -$116K 0.24% 104
2015
Q3
$8.15M Sell
87,316
-9,518
-10% -$921K 0.23% 105
2015
Q2
$9.44M Sell
96,834
-10,327
-10% -$1.03M 0.25% 104
2015
Q1
$10.8M Sell
107,161
-7,937
-7% -$807K 0.28% 99
2014
Q4
$12M Sell
115,098
-770
-0.7% -$81.1K 0.33% 95
2014
Q3
$12.3M Sell
115,868
-4,680
-4% -$485K 0.37% 90
2014
Q2
$12.6M Sell
120,548
-27,348
-18% -$2.76M 0.38% 84
2014
Q1
$14.5M Sell
147,896
-82,538
-36% -$7.65M 0.47% 76
2013
Q4
$21.1M Sell
230,434
-80,991
-26% -$7.46M 0.7% 63
2013
Q3
$27M Sell
311,425
-18,569
-6% -$1.67M 0.98% 42
2013
Q2
$28.3M Buy
+329,994
New +$28M 1.11% 39

Other funds holding JNJ

Douglas C. Lane & Associates's JNJ Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q4 2015, selling an estimated $116K and leaving 86,162 shares worth $8.85M. The position accounts for 0.24% of the portfolio, ranked #104.

Douglas C. Lane & Associates first reported a position in JNJ in Q2 2013 and has held it in 11 quarters since. The position peaked at $28.3M in Q2 2013. 2,193 funds tracked by Wall St. Rank hold JNJ as of Q4 2015.

  • Douglas C. Lane & Associates held 86,162 shares of Johnson & Johnson worth $8.85M as of Q4 2015.
  • Douglas C. Lane & Associates sold 1,154 Johnson & Johnson shares in Q4 2015, an estimated $116K.
  • Johnson & Johnson made up 0.24% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #104 holding.
  • Douglas C. Lane & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 11 quarters since.
  • Douglas C. Lane & Associates's Johnson & Johnson position peaked at $28.3M in Q2 2013.
  • 2,193 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.